| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |